Jeito Capital leads a USD 65 million Series A financing in ReproNovo to advance treatments in reproductive medicine and women's health.
Amount Raised
$65 Million
Round Type
Series A
LausanneBiotechnologyHealth CareInvestors
Description
Jeito Capital is leading a USD 65 million Series A financing round in ReproNovo to support clinical trials for its candidates RPN-001 and RPN-002. This investment highlights Jeito's commitment to innovative biopharma solutions. The funding aims to address growing infertility issues worldwide. Ksenija Pavletic from Jeito will join ReproNovo's Board of Directors.
Quick answer
ReproNovo raised $65 Million in a Series A round, dated May 21, 2025. Investors: M Ventures, Axa Im Alts, Ysios Capital, Alsa Ventures and Jeito Capital. ReproNovo is based in Lausanne, Vaud, Switzerland.
- How much did ReproNovo raise?
- ReproNovo raised $65 Million in a Series A round on May 21, 2025.
- Who invested in ReproNovo?
- M Ventures, Axa Im Alts, Ysios Capital, Alsa Ventures and Jeito Capital are named as investors in this round.
- What does ReproNovo do?
- ReproNovo is a cutting-edge biopharmaceutical company identifying and developing innovative solutions to address critical gaps in reproductive medicine and women’s health.
- Where is ReproNovo based and how big is it?
- ReproNovo is based in Lausanne, Vaud, Switzerland. Fundz records about 15 employees.
- Who are the decision-makers at ReproNovo?
- Fundz holds 1 contact at ReproNovo. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as ReproNovo that raised within 45 days of this round, from Fundz verified event records.
- Imagene raised $23M (Series B) on July 4, 2025.
- Amotio raised $1.1M (Pre-Seed) on July 3, 2025.
- Ebenbuild raised $2.7M (Grant) on July 2, 2025.
- Circulate Health raised $12M (Seed) on July 2, 2025.
- Loopworm raised $3.3M (Pre-Series A) on July 2, 2025.
- Quiver Bioscience raised $2.1M (Grant) on July 1, 2025.
Who to call at ReproNovo, and when
A new round usually means ReproNovo is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ReproNovo raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ReproNovo, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ReproNovo. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ReproNovo raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansReproNovo raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.